Products
| Catalog No | Chemical Name | CAS Number | Purity | Chemical Structure |
|---|---|---|---|---|
| 20415 | Acetic acid, 2-[[2-(1,1-diMethylethyl)phenyl]aMino]-2-oxo- | 254751-08-1 | 98% Min. | phenyl]aMino]-2-oxo-_254751-08-1.png) |
| 20413 | ACETOPHENONESEMICARBAZONE | 2492-30-0 | 98% Min. |  |
| 20400 | 2-amino-4-(4-fluorophenyl)thiazole-5-carbonitrile | 952753-59-2 | 98% Min. | thiazole-5-carbonitrile_952753-59-2.png) |
| 20397 | 4-amino-7-iodopyrrolo[2,1-f][1,2,4]triazine | 1770840-43-1 | 98% Min. |  |
| 20389 | 2-Amino-6-fluoro-3-nitropyridine | 60186-21-2 | 98% Min. |  |
| G20382 | 4-Aza-1-azoniabicyclo[2.2.2]octane, 1,1'-(1,12-dodecanediyl)bis-, dibromide (9CI) | 256448-15-4 | 98% Min. |  |
| 1711223 | Asciminib HCl | 2119669-71-3 | ≧98.0% |  |
| Asciminib, also known as ABL001, is a potent allosteric inhibitor of BCR-ABL. | ||||
| 226191 | AGN 196996 | 958295-17-5 | ≧98.0% |  |
| AGN 196996 is a potent and selective RARα antagonist with Ki value of 2 nM; little b | ||||
| L20352 | AZD5305 | 1995893-58-7 | 98% Min. |  |
| AZD5305 is a potent, selective and oral active PARP inhibitor. AZD5305 is a highly po | ||||
| 20319 | Ablukast | 96566-25-5 (free acid) | 98% Min. | |
| Ablukast is a leuktriene receptor antagonist that acts as an anti-asthmatic. | ||||
| 20312 | 2-AMINO-5-TRIFLUOROMETHYL-BENZOIC ACID | 83265-53-6 | 98% Min. |  |
| 20303 | Afabicin | 1518800-35-5 | 98% Min. |  |
| Afabicin (formerly Debio 1450, AFN-1720) is a prodrug of afabicin desphosphono, an en | ||||
| 20300 | Acoramidis (AG-10 ) | 1446711-81-4 | ≧98.0% |  |
| Acoramidis (formerly AG10) is an investigational, orally-administered small molecule | ||||
| 20298 | ASTX-029 | 2095719-92-7 | 98% Min. |  |
| ASTX029 is a highly potent and selective dual-mechanism ERK inhibitor. ASTX029 inhibi | ||||
| 20297 | AZD-4818 | 1003566-93-5 | 98% Min. |  |
| AZD-4818 is a chemokine CCR1 antagonist that is used for the treatment of chronic obs | ||||
| 20289 | Adavivint | 1467093-03-3 (free base) | 98% Min. | |
| 20286 | A2793 | 88349-90-0 | 98% Min. |  |
| A2793 is an inhibitor of TRESK (IC50 value of 6.8 μM for mTRESK). A2793 inhibited TW | ||||
| 20281 | ABT-384 | 868623-40-9 | ≧98.0% |  |
| ABT-384 is a potent and selective inhibitor of 11β-hydroxysteroid dehydrogenase type | ||||
| 20269 | AN 0128 | 872044-70-7 | 98% Min. |  |
| AN 0128, also known as CRM-0005 and ONT-0001, is a tumour necrosis factor alpha (TNF- | ||||
| 20267 | Almonertinib | 1899921-05-1 | 98% Min. |  |
| Almonertinib is an orally available inhibitor of the epidermal growth factor receptor | ||||
| 20264 | ALC-0315 | 2036272-55-4 | 98% Min. |  |
| ALC-0315 is a synthetic cationic lipid (or ionizable lipid). It is a colorless oily m | ||||
| 2105071 | AP1189 acetate | 959850-74-9 | ≧98.0% |  |
| AP1189 is a melanocortin receptor agonist on MC1 and MC3 receptors. | ||||
| 21223 | AMG-221 | 1095565-81-3 | 98% Min. |  |
| AMG-221, BVT-83370, is a potent and selective 11β-HSD1 inhibitor. AMG-221 decreased | ||||
| 20211801 | ACT-389949 (ACT389949) | 1258417-54-7 | 98% Min. |  |
| ACT-389949 is a potent and selective agonist of formyl peptide receptor type 2 (FPR2) | ||||
| 20111201 | AT-56 | 162640-98-4 | 98% Min. |  |
| AT-56 is a selective, competitive, and highly bioavailable inhibitor of lipocalin-typ | ||||
| 20103001 | ASN007 | 2055597-12-9 | ≧98.0% |  |
| ASN007 , a novel oral ERK inhibitor , has shown anti-tumor activity in both solid tum | ||||
| 2091501 | AB-680 | 2105904-82-1 | 98% Min. |  |
| AB-680 is highly potent, reversible and selective CD73 inhibitor. AB680 to be a rever | ||||
| 23948 | Apilimod mesylate ( STA-5326 ) | 870087-36-8 | ≧98.0% | _870087-36-8.png) |
| Apilimod, also known as STA-5326, is a potent IL-12/IL-23 inhibitor. Apilimod inhibit | ||||
| 2071801 | AVN-101 HCl | 1061354-48-0 | 98% | .png) |
| AVN-101 is a very potent 5-HT7 receptor antagonist (Ki = 153 pM), with slightly | ||||
| 2071628 | APX-115 freebase | 1270084-92-8 | 98% Min. |  |